Investigator-initiated phase I trial of an oligonucleotide therapeutic targeting long noncoding RNA TUG 1 for recurrent glioblastoma
Authors
- Fumiharu Ohka (ORCID: https://orcid.org/0000-0002-5569-5626)
- Keiko Shinjo (ORCID: https://orcid.org/0000-0002-7797-6453)
- Ryuta Saito (ORCID: https://orcid.org/0000-0002-2484-1360)
- Aya Sato (ORCID: https://orcid.org/0000-0002-4231-2315)
- Junya Yamaguchi (ORCID: https://orcid.org/0000-0002-4344-5750)
- Shoichi Deguchi (ORCID: https://orcid.org/0000-0003-2424-2314)
- Yoshiki Arakawa (ORCID: https://orcid.org/0000-0003-4626-4645)
- Yutaka Kondo (ORCID: https://orcid.org/0000-0003-3746-3191)
- Yoshitaka Narita (ORCID: https://orcid.org/0000-0003-4303-6006)
- Yoshiki Shiba
Institutions
- Kyoto University (JP)
- Nagoya University (JP)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-02-13
- DOI
- https://doi.org/10.1186/s12885-025-13623-0
- Citations
- 12
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 11.23
Funders
- Japan Agency for Medical Research and Development